Neurocrine Biosciences shares owned by Camden Capital
Quarter-by-quarter ownership of Neurocrine Biosciences (NBIX) shares owned by Camden Capital
from 13F filings
Historical chart of Camden Capital investment in Neurocrine Biosciences
Tip: Access up to 7 years of quarterly data
All positions including Neurocrine Biosciences held by Camden Capital consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Neurocrine Biosciences by Camden Capital
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2023-12-31 | $415k | 3.2k | 131.76 |
2021-03-31 | $225k | 2.3k | 97.40 |